Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.
about
Antigenic variability: Obstacles on the road to vaccines against traditionally difficult targets.Generation of influenza A viruses as live but replication-incompetent virus vaccines.Observational studies and the difficult quest for causality: lessons from vaccine effectiveness and impact studies.Structure-function relationships of protein-lipopeptide complexes and influence on immunogenicity.Induction of Antiviral Immune Response through Recognition of the Repeating Subunit Pattern of Viral Capsids Is Toll-Like Receptor 2 Dependent.The Toll-Like Receptor 2 agonist PEG-PamCys as an immunochemoprophylactic and immunochemotherapeutic against the liver and transmission stages of malaria parasites
P2860
Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Inactivated Influenza Vaccine ...... t Long-Term Adaptive Immunity.
@ast
Inactivated Influenza Vaccine ...... t Long-Term Adaptive Immunity.
@en
type
label
Inactivated Influenza Vaccine ...... t Long-Term Adaptive Immunity.
@ast
Inactivated Influenza Vaccine ...... t Long-Term Adaptive Immunity.
@en
prefLabel
Inactivated Influenza Vaccine ...... t Long-Term Adaptive Immunity.
@ast
Inactivated Influenza Vaccine ...... t Long-Term Adaptive Immunity.
@en
P2093
P2860
P50
P356
P1433
P1476
Inactivated Influenza Vaccine ...... t Long-Term Adaptive Immunity.
@en
P2093
Amabel C L Tan
Chinn Yi Wong
Steve Rockman
Toshiki Sekiya
Weisan Chen
P2860
P304
P356
10.1128/MBIO.01024-15
P50
P577
2015-10-27T00:00:00Z